Cited by 325Streptococcal Infections and TreatmentsInfective Endocarditis Diagnosis and ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Open access

Szekely, P.·1964·BMJ

DOI 10.1136/bmj.1.5392.1209PMC PMC1814317

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.1.5392.1209

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diseases of the Heart and Circulation
M, M. B. (1957) · Postgraduate Medical Journal · doi:10.1136/pgmj.33.377.147 · Cited by 799
An Appreciation of Mitral Stenosis--I
Wood, P. (1954) · BMJ · doi:10.1136/bmj.1.4870.1051 · Cited by 462
THE COURSE OF MITRAL STENOSIS WITHOUT SURGERY: TEN- AND TWENTY-YEAR PERSPECTIVES
Rowe, J., Bland, E. F., Sprague, H. B., & WHITE, P. D. (1960) · Annals of Internal Medicine · doi:10.7326/0003-4819-52-4-741 · Cited by 281
Systemic arterial embolism in rheumatic heart disease
Daley, R., Mattingly, T. W., Holt, C. L., Bland, E. F., & WHITE, P. D. (1951) · American Heart Journal · doi:10.1016/0002-8703(51)90152-4 · Cited by 245
The Regulation of Human Respiration
CUNNINGHAM, D. J. C., & Landmesser, C. M. (1963) · Anesthesiology · doi:10.1097/00000542-196311000-00043 · Cited by 153
Isolation of a Reovirus from a Case of Burkitt's Lymphoma
Bell, T., Massie, A., ROSS, M. G. R., & Williams, M. (1964) · BMJ · doi:10.1136/bmj.1.5392.1212 · Cited by 79
Systemic Embolism and Left Auricular Thrombosis in Relation to Mitral Valvotomy
Belcher, J., & Somerville, W. (1955) · BMJ · doi:10.1136/bmj.2.4946.1000 · Cited by 78
The Regulation of Human Respiration
Cotes, J. E. (1964) · Occupational and Environmental Medicine · doi:10.1136/oem.21.1.82 · Cited by 78
Arterial embolization in relation to mitral valvuloplasty
Ellis, L. B., & Harken, D. E. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90369-6 · Cited by 63
PROPHYLAXIS OF RECURRENT EMBOLISM OF INTRACARDIAC ORIGIN
Cosgriff, S. W. (1950) · JAMA · doi:10.1001/jama.1950.02910450010003 · Cited by 59

Show all 27 references

Sorted by citations

Items 101–200 of 323

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
Aronis, K. N., & Hylek, E. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007338 · Cited by 45
“There are no randomized controlled clinical trials assessing the benefit of VKAs in patients with rheumatic valve disease, and these recommendations are primarily based on observational studies.(56,57) Patients with rheumatic mitral valve disease were excluded from all major”
Background
Use of Oral Anticoagulants in Older Patients
Sebastian, J. L., & Tresch, D. D. (2000) · Drugs & Aging · doi:10.2165/00002512-200016060-00003 · Cited by 42
Antithrombotic treatment in atrial fibrillation
Kalra, L., & Lip, G. Y. H. (2006) · Heart · doi:10.1136/hrt.2006.099911 · Cited by 42
Echocardiographic analysis of left atrial size before and after operation in mitral valve disease
Sherrid, M. V., Clark, R. D., & Cohn, K. E. (1979) · The American Journal of Cardiology · doi:10.1016/s0002-9149(79)80001-6 · Cited by 42
Influence of percutaneous mitral commissurotomy on left atrial spontaneous contrast of mitral stenosis
Cormier, B., Vahanian, A. S., Lung, B., Porte, J. M., Dadez, E., Lazarus, A., Starkman, C., & Acar, J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90834-y · Cited by 41
A study of embolism in mitral valve disease and atrial fibrillation.
Dewar, H. A., & Weightman, D. (1983) · Heart · doi:10.1136/hrt.49.2.133 · Cited by 41
“…activity of antecubital vein blood is not, of course, the same as that in the left atrium, but previous cardiac catheterisation measurements'3 have shown that though pulmonary arteries and veins both liberate activator into the circulation, the former much more so than the latter,…”
Background
Nonatherosclerotic Causes of Stroke
Levine, J., & Swanson, P. D. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-807 · Cited by 41
Therapy of Ischemic Cerebrovascular Disease
Byer, J. A., & EASTON, J. D. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-742 · Cited by 43
Anticoagulant and Platelet-Antiaggregating Therapy in Stroke and Threatened Stroke
Dyken, M. L. (1983) · Neurologic Clinics · doi:10.1016/s0733-8619(18)31180-0 · Cited by 41
Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy
Ikeda, U., Yamamoto, K., & Shimada, K. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200104 · Cited by 38
Bleeding during oral anticoagulant therapy
Zweifler, A. J., Coon, W. W., & Willis, P. W. (1966) · American Heart Journal · doi:10.1016/0002-8703(66)90665-x · Cited by 38
Thromboembolism in mitral porcine valve recipients
Edmiston, W. A., Harrison, E. C., Gf, D., Parnassus, W. N., & Lau, F. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90007-3 · Cited by 38
2025 Clinical practice guidelines for Atrial fibrillation and flutter
Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44
Antithrombotic Therapy in Valvular Heart Disease
Levine, H. J., Pauker, S. G., & Salzman, E. W. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.98s · Cited by 37
Report of the Joint Committee for Stroke Facilities
Toole, J. F., TRUSCOTT, B. L., ANDERSON, W. W., Aronson, P. R., Blaisdell, W. F., Dustan, H. P., Dyken, M. L., Foley, A. R., Halsey, J. H., Langfitt, T. W., et al. (1973) · Stroke · doi:10.1161/01.str.4.2.270 · Cited by 37
Antithrombotic therapy in atrial fibrillation: A review of randomized trials with special reference to the stroke prevention in atrial fibrillation II (SPAF II) trial
Shivkumar, K., Jafri, S. M., & Gheorghiade, M. (1996) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(96)80018-1 · Cited by 36
Decision Analytic and Cost-Effectiveness Issues Concerning Anticoagulant Prophylaxis in Heart Disease
Eckman, M. H., Levine, H. J., & Pauker, S. G. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.538s · Cited by 36
Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease
Hwang, J., Kuan, P., Lin, S.-C., Chen, W.-J., Lei, M., Ko, Y., Cheng, J.-J., Lin, J., Chen, J.-J., & Lien, W.-P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90557-f · Cited by 35
Left Atrial Platelet Activity With Rheumatic Mitral Stenosis *
Chen, M., Wu, C., Yip, H., Chang, H., Fang, C.-Y., Yu, T., & Fu, M. (2003) · CHEST Journal · doi:10.1378/chest.124.5.1663 · Cited by 34
Left atrial dimension and risk of systemic embolism in patients with a prosthetic valve
Burchfiel, C. M., Hammermeister, K. E., Krause-Steinrauf, H. J., Sethi, G. K., Henderson, W. G., Crawford, M. H., & Wong, M. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90172-l · Cited by 33
A Clinical Evaluation of Atrial Fibrillation in Rheumatic Heart Disease.
Sharma, S., & Verma, S. (2015) · PubMed · Cited by 32
Current status of antithrombotic therapy in cardiovascular disease
Rogers, P. H., & Sherry, S. (1976) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(76)90017-7 · Cited by 32
Transient, Subclinical Atrial Fibrillation and Risk of Systemic Embolism in Patients With Rheumatic Mitral Stenosis in Sinus Rhythm
Karthikeyan, G., Ramamoorthy, A., Devasenapathy, N., Narang, R., Yadav, R. K., Seth, S., Singh, S., Goswami, K. C., & Bahl, V. K. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.06.016 · Cited by 31
The Use of Oral Anticoagulants (Warfarin) in Older People
(2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50380.x · Cited by 31
Antithrombotic Therapy in Atrial Fibrillation
DUNN, M. I., Alexander, J., de Silva, R., & Hildner, F. J. (1986) · CHEST Journal · doi:10.1378/chest.89.2_supplement.68s · Cited by 30
Making Decisions About Antithrombotic Therapy in Heart Disease
Eckman, M. H., Levine, H. J., & Pauker, S. G. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.457s · Cited by 29
Stroke
Sage, J. I. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060040025008 · Cited by 29
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Atrial fibrillation as a cause of myocardial and cerebral infarctions.
Kuramoto, K., Matsushita, S., & Yamanouchi, H. (1984) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.48.67 · Cited by 27
Long-term oral anticoagulation for atrial fibrillation in low and middle income countries
Ramakumar, V., Benz, A. P., & Karthikeyan, G. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.02.003 · Cited by 28
Role of routine transthoracic echocardiography in evaluation and management of stroke
Beattie, Cohen, Manning, & Douglas, P. S. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00300.x · Cited by 26
Antithrombotic Therapy in Valvular Heart Disease
Levine, H. J., Banker, S. G., Salzman, E. W., & Eckman, M. H. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.434s · Cited by 26
Cardioembolic Stroke
Brickner, M. E. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89525-3 · Cited by 27
Current status of anticoagulant therapy
Deykin, D. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90477-6 · Cited by 26
Thromboembolism and antithrombotic therapy in cerebrovascular disease
Sherman, D. G., & Hart, R. G. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80010-9 · Cited by 25
Atrial Fibrillation: Epidemiology and the Risk and Prevention of Stroke
Barold, S. S., Kalman, J. M., & Tonkin, A. M. (1992) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1992.tb03143.x · Cited by 25
11 The Use of Antithrombotic Drugs in Artery Disease
Gallus, A. S. (1986) · Clinics in Haematology · doi:10.1016/s0308-2261(18)30028-6 · Cited by 24
Septic Embolism: A Potentially Devastating Complication of Infective Endocarditis
Wojda, T. R., Cornejo, K. M., Lin, A., Cipriano, A., Nanda, S., Amortegui, J. D., Wojda, B. T., & Stawicki, S. P. (2016) · InTech eBooks · doi:10.5772/64931 · Cited by 22
“Of note, anatomic distribution of septic emboli associated with infective endocarditis (48–65% cerebral, 35–52% noncerebral [1, 2, 4]) approximates that of valvular atrial fibrillation (56–63% cerebral, 38–44% noncerebral [15, 16]) suggesting that structural anatomic factors play a role in the pathophysiology of embol…”
Background
Narrow Complex Tachycardias: Differential Diagnosis and Management
Sager, P. T., & Bhandari, A. K. (1991) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30268-6 · Cited by 23
Anticoagulation in Cerebral Embolism
Bass, E. (1983) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710004453x · Cited by 23
Cardiac Problems in Patients with Neurologic Disease
Kantor, H. L., & Krishnan, S. (1995) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30048-1 · Cited by 22
Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
Fanaroff, A. C., Vora, A. N., & Lópes, R. D. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab151 · Cited by 22
The unappreciated importance of blood pressure in recent and older atrial fibrillation trials
Manolis, A. J., Doumas, M. N., Poulimenos, L. E., Kallistratos, M. S., & Mancia, G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283638194 · Cited by 20
Anticoagulant Treatment to Prevent Cerebral Infarction
Millikan, C. H. (1979) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31679-0 · Cited by 20
European atrial fibrillation trial.
Dehaene, I. (1988) · PubMed · Cited by 19
Antithrombotic Therapy in Valvular Heart Disease
Levine, H. J., Pauker, S. G., & Salzman, E. W. (1986) · CHEST Journal · doi:10.1378/chest.89.2_supplement.36s · Cited by 19
Antithrombotic Therapy in Valvular Heart Disease
Levine, H. J., Pauker, S. G., & Eckman, M. H. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.360s · Cited by 19
Coagulation studies in rheumatic heart disease.
Toy, J., Lederer, D. A., Tulpule, A., Tandon, A. P., Taylor, S. H., & McNicol, G. P. (1980) · Heart · doi:10.1136/hrt.43.3.301 · Cited by 18
Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.
Stratton, J. R. (1989) · PubMed Central · Cited by 18
The incidence of thromboembolism and the hemocoagulative background in patients with rheumatic heart disease.
FUKUDA, Y., & Nakamura, K. (1984) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.48.59 · Cited by 18
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons WRITING COMMITTEE MEMBERS*
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Cited by 17
Emboli detection using a wrapper-based feature selection algorithm with multiple classifiers
Şakar, B. E., Serbes, G., & Aydın, N. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103080 · Cited by 17
Sangramento durante a anticoagulação oral: alerta sobre um mal maior
Lavítola, P. D. L., Spina, G. S., Sampaio, R. O., Tarasoutchi, F., & Grinberg, M. (2009) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2009000800017 · Cited by 17
Mechanism of Reducing Platelet Activity by Percutaneous Transluminal Mitral Valvuloplasty in Patients With Rheumatic Mitral Stenosis
Chen, M., Wu, C., Chang, H., Yip, H., Chen, Y., Cheng, C., & Chai, H. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1629 · Cited by 17
Antithrombotic therapy in atrial fibrillation
Singer, D. E., & Go, A. S. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70110-5 · Cited by 17
DIRECT CURRENT CONVERSION OF ATRIAL FIBRILLATION—LONG‐TERM RESULTS
Åberg, H. E., & Cullhed, I. (1968) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1968.tb02483.x · Cited by 17
Hemostatic changes induced by percutaneous mitral valvuloplasty
Kataoka, H., Yano, S., Tamura, A., & Mikuriya, Y. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90170-e · Cited by 17
Long-term survival after single aortic or mitral valve replacement with the present model of Smeloff-Cutter valves
McHenry, M. M., Smeloff, E. A., Matlof, H. J., Rice, J., & Miller, G. E. (1978) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)41318-4 · Cited by 16
Is Anticoagulation Therapy Underused In Elderly Patients with Atrial Fibrillation?
Turazza, F. M., & Franzosi, M. G. (1997) · Drugs & Aging · doi:10.2165/00002512-199710030-00002 · Cited by 16
Left atrial thrombi in mitral valve disease
Ullal, S. R., Kluge, T. H., Hill, J. D., Kerth, W. J., & Gerbode, F. L. A. (1971) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)41985-5 · Cited by 16
Anticoagulant therapy in recurrent cerebral embolism: a retrospective study in non-valvular atrial fibrillation
Yamanouchi, H., Nagura, H., Ohkawa, Y., Sakurai, Y., Kuzuhara, S., Kuramoto, K., Shimada, H., & TOYOKURA, Y. (1988) · Journal of Neurology · doi:10.1007/bf00314482 · Cited by 15
Effect of Warfarin on Regional Left Atrial Coagulation Activity in Mitral Stenosis
Peverill, R. E., Harris, G. M., Gelman, J. S., Gan, T. E., Harper, R. W., & Smolich, J. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00758-8 · Cited by 15
Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
Ahmad, S., & Wilt, H. (2016) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401610010110 · Cited by 14
“It is well known that patients with valvular heart disease are at heightened risk for ischemic stroke, particularly those with mitral stenosis and underlying atrial fibrillation (AF) or atrial flutter [2, 3].”
Treatment of progressing stroke
Millikan, C. H., & MCDOWELL, F. H. (1980) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(80)90015-8 · Cited by 14
Mitral valvotomy and embolism.
Bakoulas, G., & Mullard, K. S. (1966) · Thorax · doi:10.1136/thx.21.1.43 · Cited by 14
Atrial fibrillation, stroke and anticoagulation
Kitchens, J. M., & Flegel, K. M. (1986) · Journal of General Internal Medicine · doi:10.1007/bf02599816 · Cited by 14
Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study
Yamanouchi, H., Shimada, H., Tomonaga, M., & Matsushita, S. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03853.x · Cited by 13
“currence rate of embolic stroke is high not only in AF associated with rheumatic heart disease (12-15), but also in NVAF (5, 10, 11, 14, 16).”
Background
Chronic Atrial Fibrillation in the Elderly: Risks vs. Benefits of Long‐term Anticoagulation
Wilson, D. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07121.x · Cited by 13
Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation
Blustin, J. M., McBane, R. D., Ketha, S. S., & Wysokiński, W. E. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.960851 · Cited by 13
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586 · Cited by 13
Neurología y cardiología: puntos de contacto
Goldstein, L. B., & Husseini, N. E. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.12.004 · Cited by 12
Cardioembolic Stroke: Practical Considerations for Patient Risk Management and Secondary Prevention
Amin, H., Nowak, R. J., & Schindler, J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.01.2725 · Cited by 12
Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm
Belen, E., Özal, E., & Püşüroğlu, H. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0759-9 · Cited by 12
“Atrial fibrillation (AF) accompanying MS increases the risk of embolism occurrence, while many embolic events exist in patients who are developing but have sinus rhythm [2, 3].”
Background
Guidelines for the Management of Anticoagulant Therapy
Gurewich, V. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0028-1086123 · Cited by 12
Antithrombotic Therapy for Valvular Heart Disease
Rosenthal, N., & Hoit, B. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-235-3_21 · Cited by 12
“Compounding the risk of thrombus is the common presence of superimposed atrial fibrillation which imparts a sevenfold increase in the risk of TE events ( 16 ).”
Background
Antithrombotic therapy for patients with cardiac disease
Schlant, R. C., & Beller, G. A. (1988) · Current Problems in Cardiology · doi:10.1016/0146-2806(88)90008-4 · Cited by 12
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87.e1 · Cited by 11
Endomyocardial Fibrosis in Britain
Black, M., & Fowler, J. M. (1965) · BMJ · doi:10.1136/bmj.1.5436.682 · Cited by 11
Echocardiography in atrial fibrillation
Corrado, G., Klein, A. L., & Santarone, M. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000234768.50583.b8 · Cited by 11
A Decision Analytic View of Anticoagulant Prophylaxis for Thromboembolism in Heart Disease
Pauker, S. G., Eckman, M. H., & Levine, H. J. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.161s · Cited by 11
Risk Factors, Interventions and Therapeutic Agents in the Prevention of Atherosclerosis-Related Ischaemic Diseases
Verstraete, M. (1991) · Drugs · doi:10.2165/00003495-199100425-00006 · Cited by 11
“66% within 12 months of the onset of atrial fibrillation (Szekely 1964).”
Background
Atrial Fibrillation in Rheumatic Heart Disease
Bansal, A., Sarkar, P. G., & Chaturvedi, V. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00845-7 · Cited by 10
Prevention of Embolic Strokes
Dalen, J. E. (2012) · CHEST Journal · doi:10.1378/chest.11-2641 · Cited by 10
Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study
Gebreyohannes, E. A., Bhagavathula, A. S., & Tegegn, H. G. (2018) · Thrombosis Journal · doi:10.1186/s12959-018-0177-1 · Cited by 10
Perioperative management and reversal of antithrombotic therapy
Jacobs, L. G., & Nusbaum, N. J. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70114-2 · Cited by 10
Thromboembolism in patients with pericardial valves in the absence of chronic anticoagulation: 12 years' experience
García-Bengoechea, J. B., González‐Juanatey, J. R., Rubio, J. G., Durán, D., & Sierra, J. (1991) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/1010-7940(91)90226-a · Cited by 10
Spontaneous echo contrast on transthoracic echocardiography and left atrial thrombus in rheumatic mitral valve disease patients: A clinicopathologic study
Wanishsawad, C., Puavilai, W., Roongsrttong, C., & Sitthi‐Amorn, C. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171007 · Cited by 10
Prevention and Treatment of Cardioembolic Stroke
Hart, R. G. (1987) · Clinical medicine and the nervous system · doi:10.1007/978-1-4471-3129-8_7 · Cited by 10
Anticoagulants and mitral valvotomy: a nine-year survey.
Stephenson, S. (1966) · Thorax · doi:10.1136/thx.21.1.38 · Cited by 10
“…and Wright (1956) reported a series of patients with repeated emboli in which the incidence fell to one-eleventh under anticoagulant therapy, and Szekely (1964) found that the emboli were most common during the first year after the onset of atrial fibrillation, and that anticoagulants gave…”
Background
Stroke Prevention in Atrial Fibrillation
Haft, J. I. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612458148 · Cited by 10
“Two phase III clinical trials have demonstrated the efficacy of apixaban for stroke prevention in patients with NVAF.42,43 Based on the results of these studies, apixaban has filed for approval for the prevention of stroke and systemic embolism in patients with NVAF in the United States.”
BackgroundInfluential
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
Junior, C. V. S., Soeiro, A. D. M., Leal, T. C., Godoy, L. C., Biselli, B., Hata, L. A., Martins, E. B., Manta, I. C. K. A., Tavares, C. A. M., Cardozo, F. A. M., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190128 · Cited by 12
Atrial fibrillation and embolism.
Milliken, J. A. (1983) · PubMed Central · Cited by 8
Hypercoagulability in patients with mitral stenosis. From the viewpoint of the behavior of plasma antithrombin III and alpha2-plasmin inhibitor.
FUKUDA, Y., Kuroiwa, Y., Okumiya, K., Kuroiwa, N., OHSHIGE, T., Tabuchi, H., Sanada, J.-I., Takaoka, S., Minami, Y., Kataoka, H., et al. (1980) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.44.867 · Cited by 9
Why is Warfarin Underutilized in Patients with Atrial Fibrillation?
Flaker, G. C., & Schutz, J. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000011342.26830.5f · Cited by 9
Arterial embolism and atrial arrhythmias
Andersson, B., Abdon, N., & Hammarsten, J. (1989) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(89)80092-1 · Cited by 9
Cathether balloon commissurotomy in adults Part II: Mitral and other stenoses
Kulick, D. (1990) · Current Problems in Cardiology · doi:10.1016/0146-2806(90)90022-i · Cited by 9
Stroke: the way things really are.
Scheinberg, P. (1994) · Stroke · doi:10.1161/01.str.25.6.1290 · Cited by 9
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87 · Cited by 8
“중등도 이상의 승모판 협착이나 기계 판막을 가지고 있는 환자에서는 비타민 K 길항제의 사용이 권장된다(class I, level of evidence B) [24-30].”
Mitral valve replacement
Agathos, E. A., & STARR, A. M. (1993) · Current Problems in Surgery · doi:10.1016/0011-3840(93)90015-9 · Cited by 8
ATRIAL FIBRILLATION, THROMBOEMBOLISM AND ANTITHROMBOTIC THERAPY
Li‐Saw‐Hee, F. L., & Lip, G. Y. H. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11680.x · Cited by 8

Authors: Szekely, P.
Corresponding author: Szekely, P.
Venue: BMJ
Publisher: BMJ
Published: 1964-05-09
Volume: 1
Issue: 5392
Pages: 1209-1212
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.1.5392.1209
PMC: PMC1814317
OpenAlex: W2089419646
Cited by: 325
References: 27
Citations by year: 2026: 1 · 2025: 1 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 5
FWCI: 9.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: BMJ (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: systemic embolism, thromboprophylaxis, rheumatic heart disease, thromboembolism, valvular heart disease
MeSH terms: Anticoagulants, Atrial Fibrillation, Embolism, Cardiac Surgical Procedures, Humans, Mitral Valve Stenosis, Preventive Medicine, Rheumatic Heart Disease, Statistics as Topic, Thoracic Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks